Alpha-9 Oncology Inc. (Series C)

Funding Details
Awarder
Inbox
Date Award
October 23, 2024
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$175,000,000

Company Info
Company Description
Alpha-9 Oncology Inc. is a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer.
Market
Cancer treatment
Location
Boston, MA, USA
Coinvestors
General Catalyst, a16z Bio + Health, RA Capital Management, Janus Henderson Investors, Delos Capital, Digitalis Ventures, Lumira Ventures, abrdn Inc.

Links